The Providence Community Health Centers, Inc: drugs

Schedule G of this filing lists 172 drugs, with an amount and a number of claims for each, as filed. Every amount links to its page of the filing.

The schedule's total is printed as “Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement”. The filings describe the amounts in more than one way. Methods says more.

All 172 drug rows

Schedule G as filed, for The Providence Community Health Centers, Inc: 172 drugs, in the order filed
LineDrugAmount as filedClaims as filed
1Biktarvy 50/200/25 mg tablets61958250101Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.648,404.79 (Schedule G, line 1, page 9 of the filing PDF)231
2Ozempic 0.25 or 0.5 mg DOS(2 mg/3 mL)00169418113Listed by the FDA as Ozempicsemaglutide0.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP636,465.60 (Schedule G, line 2, page 9 of the filing PDF)1,897
3Ozempic 1 mg per dose (4 mg/3 mL) PFP00169413013Listed by the FDA as Ozempicsemaglutide1.34 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP438,230.08 (Schedule G, line 3, page 9 of the filing PDF)1,239
4Ozempic 2 mg per dose (8 mg/3 mL) PFP00169477212Listed by the FDA as Ozempicsemaglutide2.68 mg/mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP360,640.64 (Schedule G, line 4, page 9 of the filing PDF)1,113
5Rinvoq 15 mg ER tablets00074230630Listed by the FDA as Rinvoqupadacitinib15 mgtablet, extended releaseAbbVie Inc.273,818.39 (Schedule G, line 5, page 9 of the filing PDF)89
6Xolair inj 150 mg/mL50242021503Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.199,558.56 (Schedule G, line 6, page 9 of the filing PDF)96
7Skyrizi 150 mg/mL Singl dose pen 1 mL00074210001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.193,859.16 (Schedule G, line 7, page 9 of the filing PDF)17
8Basaglar 100 units/mL KwikPen inj 3 mL00002771559Listed by the FDA as Basaglar KwikPeninsulin glargine100 IU/mLinjection, solutionEli Lilly and Company189,229.98 (Schedule G, line 8, page 9 of the filing PDF)349
9Tremfya inj 100 mg/mL57894064011Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.171,290.76 (Schedule G, line 9, page 9 of the filing PDF)38
10Fasenra 30 mg/mL syr00310173030Listed by the FDA as Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP169,041.94 (Schedule G, line 10, page 9 of the filing PDF)44
11Trulicity 0.75 mg/0.5 mL inj (4 pens)00002143380Listed by the FDA as Trulicitydulaglutide0.75 mg/0.5 mLinjection, solutionEli Lilly and Company130,120.49 (Schedule G, line 11, page 9 of the filing PDF)295
12Rybelsus 14 mg tablets00169431430Listed by the FDA as Rybelsusoral semaglutide14 mgtabletNovo Nordisk Pharmaceutical Industries, LP100,896.73 (Schedule G, line 12, page 9 of the filing PDF)204
13Dovato 50-300 mg tablets49702024613Listed by the FDA as Dovatodolutegravir sodium and lamivudine50 mg; 300 mgtablet, film coatedViiV Healthcare Company99,898.56 (Schedule G, line 13, page 9 of the filing PDF)45
14Erleada59676060012Listed by the FDA as Erleadaapalutamide60 mgtablet, film coatedJanssen Products, LP98,194.08 (Schedule G, line 14, page 9 of the filing PDF)10
15Xolair inj 150 mg/mL50242021501Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.the product is listed, not this package97,035.38 (Schedule G, line 15, page 9 of the filing PDF)57
16Fasenra pen inj 30 mg/mL00310183030Listed by the FDA as Fasenrabenralizumab30 mg/mLinjection, solutionAstraZeneca Pharmaceuticals LP96,098.63 (Schedule G, line 16, page 9 of the filing PDF)24
17Wegovy 2.4 mg/0.75 mL inj (4 pens)00169452414Listed by the FDA as Wegovysemaglutide2.4 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP93,099.97 (Schedule G, line 17, page 9 of the filing PDF)157
18Paxlovid new 300/100 mg T standard00069532130Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc91,793.24 (Schedule G, line 18, page 9 of the filing PDF)91
19Cosentyx Uno inj 300/2 mL00078107068Listed by the FDA as Cosentyxsecukinumab300 mg/2 mLinjectionNovartis Pharmaceuticals Corporation83,771.19 (Schedule G, line 19, page 9 of the filing PDF)32
20Skyrizi inj 150 mg/mL00074105001Listed by the FDA as Skyrizirisankizumab-rzaa150 mg/mLinjectionAbbVie Inc.79,833.55 (Schedule G, line 20, page 10 of the filing PDF)7
21Vosevi tablets61958240101Listed by the FDA as Vosevisofosbuvir, velpatasvir, and voxilaprevir400 mg; 100 mg; 100 mgtablet, film coatedGilead Sciences, Inc.75,305.94 (Schedule G, line 21, page 10 of the filing PDF)fewer than 6 (the count is not shown)
22Trelegy Ellipta 100-62.5 mcg inh 30P00173088710Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate100 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC73,000.87 (Schedule G, line 22, page 10 of the filing PDF)280
23Trulicity 1.5 mg/0.5 mL inj (4 pens)00002143480Listed by the FDA as Trulicitydulaglutide1.5 mg/0.5 mLinjection, solutionEli Lilly and Company71,521.15 (Schedule G, line 23, page 10 of the filing PDF)180
24Trulicity 3 mg/0.5 mL inj (4 pens)00002223680Listed by the FDA as Trulicitydulaglutide3 mg/0.5 mLinjection, solutionEli Lilly and Company70,339.10 (Schedule G, line 24, page 10 of the filing PDF)85
25Mounjaro 5 mg/0.5 mL inj (4 pens)00002149580Listed by the FDA as Mounjarotirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company68,202.46 (Schedule G, line 25, page 10 of the filing PDF)73
26Wegovy 1.7 mg/0.75 mL inj ( 4 pens)00169451714Listed by the FDA as Wegovysemaglutide1.7 mg/0.75 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP66,826.37 (Schedule G, line 26, page 10 of the filing PDF)113
27Descovy 200 mg/25 mg tablets61958200201Listed by the FDA as Descovyemtricitabine and tenofovir alafenamide200 mg; 25 mgtabletGilead Sciences, Inc.61,907.51 (Schedule G, line 27, page 10 of the filing PDF)56
28Rinvoq 45 mg ER tablets00074104328Listed by the FDA as Rinvoqupadacitinib45 mgtablet, extended releaseAbbVie Inc.59,641.01 (Schedule G, line 28, page 10 of the filing PDF)10
29Trelegy Ellipta 200-62.5 mcg inh 30P00173089310Listed by the FDA as Trelegy Elliptafluticasone furoate, umeclidinium bromide and vilanterol trifenatate200 mcg; 62.5 mcg; 25 mcgpowderGlaxoSmithKline LLC58,560.58 (Schedule G, line 29, page 10 of the filing PDF)207
30Wegovy 1 mg/0.5 mL inj (4 pens)00169450114Listed by the FDA as Wegovysemaglutide1 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP57,281.63 (Schedule G, line 30, page 10 of the filing PDF)97
31Stelara 90 mg/mL PFS57894006103Listed by the FDA as Stelaraustekinumab90 mg/mLinjection, solutionJanssen Biotech, Inc.56,317.63 (Schedule G, line 31, page 10 of the filing PDF)7
32Rybelsus 7 mg tablets00169430730Listed by the FDA as Rybelsusoral semaglutide7 mgtabletNovo Nordisk Pharmaceutical Industries, LP55,890.93 (Schedule G, line 32, page 10 of the filing PDF)127
33Wegovy 0.5 mg/0.5 mL inj (4 pens)00169450514Listed by the FDA as Wegovysemaglutide0.5 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP52,479.20 (Schedule G, line 33, page 10 of the filing PDF)89
34Mounjaro 7.5 mg/0.5 mL inj (4 pens)00002148480Listed by the FDA as Mounjarotirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company52,049.28 (Schedule G, line 34, page 10 of the filing PDF)54
35Nucala inj 100 mg/mL00173089242Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC51,361.00 (Schedule G, line 35, page 10 of the filing PDF)20
36Dapagliflozin 5 mg tablets66993045630Listed by the FDA as Dapagliflozin5 mgtablet, film coatedPrasco Laboratories50,756.04 (Schedule G, line 36, page 10 of the filing PDF)209
37Nurtec 75 mg ODT tablets72618300002Listed by the FDA as Nurtec ODTrimegepant sulfate75 mgtablet, orally disintegratingPfizer Laboratories Div Pfizer Inc50,741.25 (Schedule G, line 37, page 10 of the filing PDF)95
38Mounjaro 2.5 mg/0.5 mL inj ( 4 pens)00002150680Listed by the FDA as Mounjarotirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company50,229.37 (Schedule G, line 38, page 10 of the filing PDF)64
39Mavyret tab 100-40 mg00074262528Listed by the FDA as Mavyretglecaprevir and pibrentasvir40 mg; 100 mgtablet, film coatedAbbVie Inc.48,447.48 (Schedule G, line 39, page 10 of the filing PDF)fewer than 6 (the count is not shown)
40Wegovy 0.25 mg/0.5 mL inj ( 4 pens)00169452514Listed by the FDA as Wegovysemaglutide0.25 mg/0.5 mLinjection, solutionNovo Nordisk Pharmaceutical Industries, LP48,025.94 (Schedule G, line 40, page 10 of the filing PDF)84
41Tremfya inj 100 mg/mL57894064001Listed by the FDA as Tremfyaguselkumab100 mg/mLinjectionJanssen Biotech, Inc.47,844.99 (Schedule G, line 41, page 10 of the filing PDF)11
42Trulicity 4.5 mg/0.5 mL inj (4 pens)00002318280Listed by the FDA as Trulicitydulaglutide4.5 mg/0.5 mLinjection, solutionEli Lilly and Company46,814.14 (Schedule G, line 42, page 10 of the filing PDF)51
43Genvoya (150/150/200/TAF10) tab61958190101Listed by the FDA as Genvoyaelvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide150 mg; 150 mg; 200 mg; 10 mgtabletGilead Sciences, Inc.46,642.14 (Schedule G, line 43, page 10 of the filing PDF)19
44Humira pen 40 mg/0.4 mL kit(2pens)CF00074055402Listed by the FDA as HumiraadalimumabkitAbbVie Inc.46,414.82 (Schedule G, line 44, page 10 of the filing PDF)32
45Cosentyx pen inj 300dose00078063941Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation45,616.02 (Schedule G, line 45, page 10 of the filing PDF)29
46Entresto 24-26 mg tablets00078065920Listed by the FDA as Entrestosacubitril and valsartan24 mg; 26 mgtablet, film coatedNovartis Pharmaceuticals Corporation43,830.73 (Schedule G, line 46, page 10 of the filing PDF)109
47Paxlovid standard dose 300/100 mg T00069504530Listed by the FDA as Paxlovidnirmatrelvir and ritonavirkitPfizer Laboratories Div Pfizer Inc43,213.60 (Schedule G, line 47, page 10 of the filing PDF)40
48Lonsurf64842102003Listed by the FDA as Lonsurftrifluridine and tipiracil20 mg; 8.19 mgtablet, film coatedTaiho Pharmaceutical Co., Ltd.43,091.00 (Schedule G, line 48, page 10 of the filing PDF)fewer than 6 (the count is not shown)
49Ilumya inj 100 mg/mL47335017795Listed by the FDA as Ilumyatildrakizumab-asmn100 mg/mLinjection, solutionSun Pharmaceutical Industries, Inc.37,651.12 (Schedule G, line 49, page 10 of the filing PDF)fewer than 6 (the count is not shown)
50Botox 200 units inj, 1 vial00023392102Listed by the FDA as BotoxonabotulinumtoxinA200 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.35,529.88 (Schedule G, line 50, page 10 of the filing PDF)37
51Budesonide/FORM 160/4.5 mcg(120 inh)00310737020Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate160 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP35,400.09 (Schedule G, line 51, page 10 of the filing PDF)313
52Mounjaro 10 mg/0.5 mL inj (4 pens)00002147180Listed by the FDA as Mounjarotirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company35,319.54 (Schedule G, line 52, page 10 of the filing PDF)34
53Entresto 49-51 mg tablets00078077720Listed by the FDA as Entrestosacubitril and valsartan49 mg; 51 mgtablet, film coatedNovartis Pharmaceuticals Corporation34,893.52 (Schedule G, line 53, page 10 of the filing PDF)80
54Botox 100 units injection00023114501Listed by the FDA as BotoxonabotulinumtoxinA100 USP unitsinjection, powder, lyophilized, for solutionAllergan, Inc.34,577.20 (Schedule G, line 54, page 10 of the filing PDF)46
55Budesonide/FORM 80/4.5 mcg (120 inh)00310737220Listed by the FDA as Budesonide and Formoterol Fumarate Dihydrate80 mcg; 4.5 mcgaerosolAstraZeneca Pharmaceuticals LP31,771.59 (Schedule G, line 55, page 10 of the filing PDF)335
56Erleada59676060430Listed by the FDA as Erleadaapalutamide240 mgtablet, film coatedJanssen Products, LP30,659.52 (Schedule G, line 56, page 10 of the filing PDF)fewer than 6 (the count is not shown)
57Prolia 60 mg/mL PF syr inj, 1 mL55513071021Listed by the FDA as Proliadenosumab60 mg/mLinjectionAmgen, Inc29,865.49 (Schedule G, line 57, page 10 of the filing PDF)36
58Juluca 50-25 mg tablets49702024213Listed by the FDA as Julucadolutegravir sodium and rilpivirine hydrochloride50 mg; 25 mgtablet, film coatedViiV Healthcare Company29,622.81 (Schedule G, line 58, page 11 of the filing PDF)12
59Zepbound 2.5 mg/0.5 mL inj (4PF pens)00002250680Listed by the FDA as Zepboundtirzepatide2.5 mg/0.5 mLinjection, solutionEli Lilly and Company28,297.07 (Schedule G, line 59, page 11 of the filing PDF)34
60Gamunex-C inj 20 g/20013533080024Listed by the FDA as Gamunex-Cimmune globulin (human)10 g/100 mLinjectionGrifols USA, LLC27,872.13 (Schedule G, line 60, page 11 of the filing PDF)11
61Ubrelvy 100 mg tablets00023650110Listed by the FDA as Ubrelvyubrogepant100 mgtabletAllergan, Inc.27,829.29 (Schedule G, line 61, page 11 of the filing PDF)65
62Xifaxan 550 mg tablets65649030302Listed by the FDA as Xifaxanrifaximin550 mgtabletSalix Pharmaceuticals, Inc.27,408.96 (Schedule G, line 62, page 11 of the filing PDF)20
63Qulipta 60 mg tablets00074709430Listed by the FDA as Quliptaatogepant60 mgtabletAbbVie Inc.27,134.13 (Schedule G, line 63, page 11 of the filing PDF)66
64Lynparza00310067912Listed by the FDA as Lynparzaolaparib150 mgtablet, film coatedAstraZeneca Pharmaceuticals LP25,922.10 (Schedule G, line 64, page 11 of the filing PDF)fewer than 6 (the count is not shown)
65Xolair inj 300/2 mL50242022701Listed by the FDA as Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc.25,553.59 (Schedule G, line 65, page 11 of the filing PDF)10
66Austedo XR tab 12 mg68546047156Listed by the FDA as Austedo XRdeutetrabenazine12 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.25,233.77 (Schedule G, line 66, page 11 of the filing PDF)8
67Rybelsus 3 mg tablets00169430330Listed by the FDA as Rybelsusoral semaglutide3 mgtabletNovo Nordisk Pharmaceutical Industries, LP24,446.31 (Schedule G, line 67, page 11 of the filing PDF)69
68Epinephrine 0.3 mg inj 2 pack00115169449Listed by the FDA as Epinephrine0.3 mg/0.3 mLinjectionAmneal Pharmaceuticals of New York LLC24,306.82 (Schedule G, line 68, page 11 of the filing PDF)269
69Dapagliflozin 10 mg tablets66993045730Listed by the FDA as Dapagliflozin10 mgtablet, film coatedPrasco Laboratories23,976.53 (Schedule G, line 69, page 11 of the filing PDF)97
70Entresto 97-103 mg tablets00078069620Listed by the FDA as Entrestosacubitril and valsartan97 mg; 103 mgtablet, film coatedNovartis Pharmaceuticals Corporation23,885.04 (Schedule G, line 70, page 11 of the filing PDF)45
71Fluticasone HFA 44 mcg inh 120inh66993007896Listed by the FDA as Fluticasone Propionate HFA44 mcgaerosol, meteredPrasco Laboratories23,310.73 (Schedule G, line 71, page 11 of the filing PDF)336
72Ingrezza cap 80 mg70370108001Listed by the FDA as Ingrezzavalbenazine80 mgcapsuleNeurocrine Biosciences, Inc.23,263.68 (Schedule G, line 72, page 11 of the filing PDF)6
73Tivicay 50 mg tablets49702022813Listed by the FDA as Tivicaydolutegravir sodium50 mgtablet, film coatedViiV Healthcare Company22,604.87 (Schedule G, line 73, page 11 of the filing PDF)22
74Mounjaro 12.5 mg/0.5 mL inj (4 pens)00002146080Listed by the FDA as Mounjarotirzepatide12.5 mg/0.5 mLinjection, solutionEli Lilly and Company22,313.80 (Schedule G, line 74, page 11 of the filing PDF)22
75Mekinist tab 0.5 mg00078110515Listed by the FDA as Mekinisttrametinib0.5 mgtablet, film coatedNovartis Pharmaceuticals Corporation20,888.47 (Schedule G, line 75, page 11 of the filing PDF)9
76Fluticasone HFA 110 mcg oral inh66993007996Listed by the FDA as Fluticasone Propionate HFA110 mcgaerosol, meteredPrasco Laboratories20,289.61 (Schedule G, line 76, page 11 of the filing PDF)221
77Odefsey (FTC200/RPV25/TAF25) tab61958210101Listed by the FDA as Odefseyemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide200 mg; 25 mg; 25 mgtabletGilead Sciences, Inc.20,115.66 (Schedule G, line 77, page 11 of the filing PDF)9
78Zoryve 0.3% topical foam 60 g80610043060Listed by the FDA as Zoryveroflumilast3 mg/gaerosol, foamArcutis Biotherapeutics, Inc.19,220.86 (Schedule G, line 78, page 11 of the filing PDF)32
79Belbuca 900 mcg buccal film59385002760Listed by the FDA as Belbucabuprenorphine hydrochloride900 mcgfilm, solubleBioDelivery Sciences International Inc19,152.53 (Schedule G, line 79, page 11 of the filing PDF)61
80Zarxio61314032610Listed by the FDA as Zarxiofilgrastim-sndz480 mcg/0.8 mLinjection, solutionSandoz Inc.19,146.75 (Schedule G, line 80, page 11 of the filing PDF)fewer than 6 (the count is not shown)
81Bimzelx inj 320 mg/250474078284Listed by the FDA as Bimzelxbimekizumab320 mg/2 mLinjection, solutionUCB, Inc.18,443.61 (Schedule G, line 81, page 11 of the filing PDF)fewer than 6 (the count is not shown)
82Zepbound 5 mg/0.5 mL inj (4 PF pens)00002249580Listed by the FDA as Zepboundtirzepatide5 mg/0.5 mLinjection, solutionEli Lilly and Company18,269.34 (Schedule G, line 82, page 11 of the filing PDF)22
83Actemra inj 162/0.950242013801Listed by the FDA as Actemratocilizumab162 mg/0.9 mLinjection, solutionGenentech, Inc.18,030.88 (Schedule G, line 83, page 11 of the filing PDF)8
84Invokana 100 mg tablets50458014030Listed by the FDA as Invokanacanagliflozin100 mgtablet, film coatedJanssen Pharmaceuticals, Inc.18,028.20 (Schedule G, line 84, page 11 of the filing PDF)77
85Benlysta inj 200 mg/mL49401008847Listed by the FDA as Benlystabelimumab200 mg/mLsolutionGlaxoSmithKline LLC17,787.65 (Schedule G, line 85, page 11 of the filing PDF)fewer than 6 (the count is not shown)
86Vemlidy 25 mg tablets61958230101Listed by the FDA as Vemlidytenofovir alafenamide25 mgtabletGilead Sciences, Inc.17,058.69 (Schedule G, line 86, page 11 of the filing PDF)13
87Breo Ellipta 100-25 mcg oral inh(30)00173085910Listed by the FDA as Breo Elliptafluticasone furoate and vilanterol trifenatate100 mcg; 25 mcgpowderGlaxoSmithKline LLC16,539.79 (Schedule G, line 87, page 11 of the filing PDF)171
88Stelara inj 45/0.5 mL57894006003Listed by the FDA as Stelaraustekinumab45 mg/0.5 mLinjection, solutionJanssen Biotech, Inc.16,501.80 (Schedule G, line 88, page 11 of the filing PDF)fewer than 6 (the count is not shown)
89Prevymis tab 480 mg00006307602Listed by the FDA as Prevymisletermovir480 mgtablet, film coatedMerck Sharp & Dohme LLC15,706.12 (Schedule G, line 89, page 11 of the filing PDF)fewer than 6 (the count is not shown)
90Jardiance 10 mg tablets00597015230Listed by the FDA as Jardianceempagliflozin10 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.15,393.41 (Schedule G, line 90, page 11 of the filing PDF)743
91Hizentra inj 10/50 mL44206045525Listed by the FDA as Hizentrahuman immunoglobulin G0.2 g/mLliquidCSL Behring AG15,175.52 (Schedule G, line 91, page 11 of the filing PDF)7
92Caplyta cap 42 mg72060014240Listed by the FDA as Caplytalumateperone42 mgcapsuleIntra-Cellular Therapies, Inc15,110.86 (Schedule G, line 92, page 11 of the filing PDF)10
93Zafemy Patches65162035803Listed by the FDA as Zafemynorelgestromin and ethinyl estradiol150 mcg/day; 35 mcg/daypatchAmneal Pharmaceuticals LLC14,520.29 (Schedule G, line 93, page 11 of the filing PDF)146
94Zepbound 10 mg/0.5 mL inj (4 PF pens)00002247180Listed by the FDA as Zepboundtirzepatide10 mg/0.5 mLinjection, solutionEli Lilly and Company14,154.21 (Schedule G, line 94, page 11 of the filing PDF)17
95Jardiance 25 mg tablets00597015330Listed by the FDA as Jardianceempagliflozin25 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.14,140.92 (Schedule G, line 95, page 11 of the filing PDF)912
96Vraylar 3 mg capsules61874013030Listed by the FDA as Vraylarcariprazine3 mgcapsule, gelatin coatedAllergan, Inc.14,097.02 (Schedule G, line 96, page 12 of the filing PDF)17
97Wixela Inhub Diskus 250/50 mcg 60S00378932132Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol250 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.13,605.51 (Schedule G, line 97, page 12 of the filing PDF)292
98Vascepa cap 1 g52937000120Listed by the FDA as Vascepaicosapent ethyl1,000 mgcapsuleAmarin Pharma Inc.13,445.92 (Schedule G, line 98, page 12 of the filing PDF)25
99Steglatro 15 mg tablets00006536403Listed by the FDA as Steglatroertugliflozin15 mgtablet, film coatedMerck Sharp & Dohme LLC13,151.21 (Schedule G, line 99, page 12 of the filing PDF)54
100Insulin Glarg-yfgn 100 units/mL pen inj83257001532Listed by the FDA as Insulin Glargineinsulin glargine-yfgn100 IU/mLinjection, solutionBiocon Biologics Inc.12,909.52 (Schedule G, line 100, page 12 of the filing PDF)346
101Ubrelvy 50 mg tablets00023649810Listed by the FDA as Ubrelvyubrogepant50 mgtabletAllergan, Inc.12,857.37 (Schedule G, line 101, page 12 of the filing PDF)25
102Januvia 100 mg tablets00006027731Listed by the FDA as Januviasitagliptin100 mgtablet, film coatedMerck Sharp & Dohme LLC12,608.00 (Schedule G, line 102, page 12 of the filing PDF)204
103Apretude 600 mg/3 mL ER inj susp, 3 mL49702026423Listed by the FDA as ApretudecabotegravirkitViiV Healthcare Company12,553.06 (Schedule G, line 103, page 12 of the filing PDF)fewer than 6 (the count is not shown)
104Mounjaro 15 mg/0.5 mL inj ( 4 pens)00002145780Listed by the FDA as Mounjarotirzepatide15 mg/0.5 mLinjection, solutionEli Lilly and Company12,231.78 (Schedule G, line 104, page 12 of the filing PDF)13
105Qvar Redihaler 80 mcg Oralinh (120)59310030480Listed by the FDA as Qvar Redihalerbeclomethasone dipropionate HFA80 mcgaerosol, meteredTeva Respiratory, LLC11,958.64 (Schedule G, line 105, page 12 of the filing PDF)159
106Qvar Redihaler 40 mcg Oralinh (120)59310030240Listed by the FDA as Qvar Redihalerbeclomethasone dipropionate HFA40 mcgaerosol, meteredTeva Respiratory, LLC11,867.75 (Schedule G, line 106, page 12 of the filing PDF)186
107Albuterol HFA inh (200 puffs) 18 g66993001968Listed by the FDA as Albuterol Sulfate HFA90 mcgaerosol, meteredPrasco Laboratories11,859.45 (Schedule G, line 107, page 12 of the filing PDF)528
108Incruse Ellipta 62.5 mcg oral inh 3000173087310Listed by the FDA as Incruse Elliptaumeclidinium62.5 mcgaerosol, powderGlaxoSmithKline LLC11,829.40 (Schedule G, line 108, page 12 of the filing PDF)138
109Xolair inj 300/2 mL50242022755Listed by the FDA as Xolairomalizumab300 mg/2 mLinjection, solutionGenentech, Inc.11,657.98 (Schedule G, line 109, page 12 of the filing PDF)6
110Tysabri inj 300/15 mL64406000801Listed by the FDA as Tysabrinatalizumab300 mg/15 mLinjectionBiogen Inc.11,226.05 (Schedule G, line 110, page 12 of the filing PDF)8
111Gemtesa 75 mg tablets73336007530Listed by the FDA as Gemtesavibegron75 mgtablet, film coatedSumitomo Pharma America, Inc.11,093.91 (Schedule G, line 111, page 12 of the filing PDF)46
112Kerendia tab 10 mg50419054001Listed by the FDA as Kerendiafinerenone10 mgtablet, film coatedBayer HealthCare Pharmaceuticals Inc.10,880.79 (Schedule G, line 112, page 12 of the filing PDF)21
113Yeztugo 463.5 mg/1.5 mL inj, 2x1.5 mL61958340201Listed by the FDA as Yeztugolenacapavir sodiumkitGilead Sciences, Inc.10,849.82 (Schedule G, line 113, page 12 of the filing PDF)fewer than 6 (the count is not shown)
114Xolair inj 150 mg/mL50242021555Listed by the FDA as Xolair PFSomalizumab150 mg/mLinjection, solutionGenentech, Inc.10,664.08 (Schedule G, line 114, page 12 of the filing PDF)7
115Simlandi 2PN 40/0.4 mL auto-inj kit51759040202Listed by the FDA as Simlandiadalimumab-ryvkkitTeva Pharmaceuticals USA, Inc.10,649.08 (Schedule G, line 115, page 12 of the filing PDF)20
116Copaxone inj 40 mg/mL68546032512Listed by the FDA as Copaxoneglatiramer acetate40 mg/mLinjection, solutionTeva Neuroscience, Inc.10,571.79 (Schedule G, line 116, page 12 of the filing PDF)8
117Invega Sustenna 234 mg/1.5 mL inj50458056401Listed by the FDA as Invega Sustennapaliperidone palmitate234 mg/1.5 mLinjectionJanssen Pharmaceuticals, Inc.10,524.93 (Schedule G, line 117, page 12 of the filing PDF)9
118Epclusa tab 400-10061958220101Listed by the FDA as Epclusavelpatasvir and sofosbuvir100 mg; 400 mgtablet, film coatedGilead Sciences, Inc.10,483.20 (Schedule G, line 118, page 12 of the filing PDF)fewer than 6 (the count is not shown)
119Combivent Respimat oral 120spray 4 g00597002402Listed by the FDA as Combivent Respimatipratropium bromide and albuterol20 mcg; 100 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.10,251.04 (Schedule G, line 119, page 12 of the filing PDF)46
120Alogliptin 25 mg tablets45802015065Listed by the FDA as Alogliptin25 mgtablet, film coatedPadagis Israel Pharmaceuticals Ltd10,122.89 (Schedule G, line 120, page 12 of the filing PDF)126
121Cetirizine 1 mg/mL oral solution00121087416Listed by the FDA as Cetirizine Hydrochloride1 mg/mLsolutionPAI Holdings, LLC dba PAI Pharma10,116.96 (Schedule G, line 121, page 12 of the filing PDF)566
122Hadlima push inj 40/0.4 mL78206018701Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC10,097.92 (Schedule G, line 122, page 12 of the filing PDF)13
123Zepbound 7.5 mg/0.5 mL inj(4PF pens)00002248480Listed by the FDA as Zepboundtirzepatide7.5 mg/0.5 mLinjection, solutionEli Lilly and Company9,970.39 (Schedule G, line 123, page 12 of the filing PDF)12
124Emgality 120 mg/mL auto injector 1 mL00002143611Listed by the FDA as Emgalitygalcanezumab-gnlm120 mg/mLinjection, solutionEli Lilly and Company9,926.88 (Schedule G, line 124, page 12 of the filing PDF)18
125Cosentyx pen inj 150 mg/mL00078063968Listed by the FDA as Cosentyxsecukinumab150 mg/mLinjectionNovartis Pharmaceuticals Corporation9,920.99 (Schedule G, line 125, page 12 of the filing PDF)15
126Taltz 80 mg/mL pen (1=1)00002144511Listed by the FDA as Taltzixekizumab80 mg/mLinjection, solutionEli Lilly and Company9,868.29 (Schedule G, line 126, page 12 of the filing PDF)fewer than 6 (the count is not shown)
127Xulane Patches00378334053Listed by the FDA as Xulanenorelgestromin and ethinyl estradiol150 mcg/day; 35 mcg/daypatchMylan Pharmaceuticals Inc.9,865.58 (Schedule G, line 127, page 12 of the filing PDF)65
128Vraylar 1.5 mg capsules61874011530Listed by the FDA as Vraylarcariprazine1.5 mgcapsule, gelatin coatedAllergan, Inc.9,750.38 (Schedule G, line 128, page 12 of the filing PDF)12
129Austedo XR tab 24 mg68546047256Listed by the FDA as Austedo XRdeutetrabenazine24 mgtablet, film coated, extended releaseTeva Neuroscience, Inc.9,576.76 (Schedule G, line 129, page 12 of the filing PDF)fewer than 6 (the count is not shown)
130Adbry inj 300/2 mL50222035002Listed by the FDA as Adbrytralokinumab-ldrm300 mg/2 mLinjection, solutionLEO Pharma Inc.9,536.06 (Schedule G, line 130, page 12 of the filing PDF)fewer than 6 (the count is not shown)
131Rinvoq tab 30 mg ER00074231030Listed by the FDA as Rinvoqupadacitinib30 mgtablet, extended releaseAbbVie Inc.9,443.86 (Schedule G, line 131, page 12 of the filing PDF)fewer than 6 (the count is not shown)
132Valtoco 10 mg nasal spr (5x10 mg spr)72252051005Listed by the FDA as Valtocodiazepam10 mg/0.1 mLsprayNeurelis, Inc8,796.38 (Schedule G, line 132, page 12 of the filing PDF)7
133Tresiba Flextouch pen (U-100)inj3 mL00169266015Listed by the FDA as Tresibainsulin degludec100 units/mLinjection, solutionNovo Nordisk8,707.60 (Schedule G, line 133, page 12 of the filing PDF)90
134Opzelura 1.5% cream 60 g50881000705Listed by the FDA as Opzeluraruxolitinib15 mg/gcreamIncyte Corporation8,645.85 (Schedule G, line 134, page 13 of the filing PDF)7
135Qulipta 30 mg tablets00074709630Listed by the FDA as Quliptaatogepant30 mgtabletAbbVie Inc.8,296.32 (Schedule G, line 135, page 13 of the filing PDF)20
136Enbrel 50 mg/mL inj (4 Syringes)58406002104Listed by the FDA as Enbreletanercept50 mg/mLsolutionImmunex Corporation8,058.12 (Schedule G, line 136, page 13 of the filing PDF)fewer than 6 (the count is not shown)
137Slynd 4 mg tablets 28S00642747001Listed by the FDA as SlynddrospirenonekitExeltis USA, Inc.7,863.24 (Schedule G, line 137, page 13 of the filing PDF)44
138Steglatro 5 mg tablets00006536303Listed by the FDA as Steglatroertugliflozin5 mgtablet, film coatedMerck Sharp & Dohme LLC7,778.05 (Schedule G, line 138, page 13 of the filing PDF)29
139Wixela Inhub Diskus 500/50 mcg 60S00378932232Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol500 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.7,707.16 (Schedule G, line 139, page 13 of the filing PDF)99
140Nucala inj 100 mg/mL00173089201Listed by the FDA as Nucalamepolizumab100 mg/mLinjection, solutionGlaxoSmithKline LLC7,704.15 (Schedule G, line 140, page 13 of the filing PDF)fewer than 6 (the count is not shown)
141Flutic/Vilan 200-25 mcg oral inh(30)66993013697Listed by the FDA as Fluticasone Furoate and Vilanterol200 mcg; 25 mcgpowderPrasco Laboratories7,476.71 (Schedule G, line 141, page 13 of the filing PDF)44
142Flutic/Vilan 100-25 mcg oral inh(30)66993013597Listed by the FDA as Fluticasone Furoate and Vilanterol100 mcg; 25 mcgpowderPrasco Laboratories7,444.90 (Schedule G, line 142, page 13 of the filing PDF)50
143Ajovy 225 mg/1.5 mL PF AUT inj 1.5 mL51759020210Listed by the FDA as Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.7,423.58 (Schedule G, line 143, page 13 of the filing PDF)37
144Dupixent 300 mg/2 mL PF pen 2x2 mL00024591502Listed by the FDA as Dupixentdupilumab300 mg/2 mLinjection, solutionSanofi-Aventis U.S. LLC7,395.69 (Schedule G, line 144, page 13 of the filing PDF)fewer than 6 (the count is not shown)
145Vivitrol 380 mg inj, 1 vial65757030001Listed by the FDA as VivitrolnaltrexonekitAlkermes, Inc.7,247.44 (Schedule G, line 145, page 13 of the filing PDF)10
146Orencia 125 mg/mL PF syr 4x1 mL00003218811Listed by the FDA as Orenciaabatacept125 mg/mLinjection, solutionE.R. Squibb & Sons, L.L.C.7,226.35 (Schedule G, line 146, page 13 of the filing PDF)fewer than 6 (the count is not shown)
147Mirabegron 25 mg ER tablets68180015106Listed by the FDA as Mirabegron25 mgtablet, film coated, extended releaseLupin Pharmaceuticals, Inc.7,203.36 (Schedule G, line 147, page 13 of the filing PDF)37
148Spiriva Respimat 2.5 mcg inh 4 g 60D00597010061Listed by the FDA as Spiriva Respimattiotropium bromide inhalation spray3.124 mcgspray, meteredBoehringer Ingelheim Pharmaceuticals, Inc.7,090.69 (Schedule G, line 148, page 13 of the filing PDF)81
149Xcopri 200 mg tablets71699020030Listed by the FDA as Xcopricenobamate200 mgtablet, film coatedSK Life Science, Inc.7,039.02 (Schedule G, line 149, page 13 of the filing PDF)fewer than 6 (the count is not shown)
150Hadlima inj 40/0.4 mL78206018601Listed by the FDA as Hadlimaadalimumab-bwwd40 mg/0.4 mLsolutionOrganon LLC6,942.32 (Schedule G, line 150, page 13 of the filing PDF)11
151Xolair inj 75/0.550242021403Listed by the FDA as Xolair PFSomalizumab75 mg/0.5 mLinjection, solutionGenentech, Inc.6,941.56 (Schedule G, line 151, page 13 of the filing PDF)8
152Vraylar cap 4.5 mg61874014530Listed by the FDA as Vraylarcariprazine4.5 mgcapsule, gelatin coatedAllergan, Inc.6,874.98 (Schedule G, line 152, page 13 of the filing PDF)8
153Lantus Solostar pen inj 3 mL00088221905Listed by the FDA as Lantus Solostarinsulin glargine100 IU/mLinjection, solutionsanofi-aventis U.S. LLC6,728.10 (Schedule G, line 153, page 13 of the filing PDF)470
154Invokana 300 mg tablets50458014130Listed by the FDA as Invokanacanagliflozin300 mgtablet, film coatedJanssen Pharmaceuticals, Inc.6,436.07 (Schedule G, line 154, page 13 of the filing PDF)32
155Ajovy 225 mg/1.5 mL PF syr 1.5 mL51759020410Listed by the FDA as Ajovyfremanezumab-vfrm225 mg/1.5 mLinjectionTeva Pharmaceuticals USA, Inc.6,430.35 (Schedule G, line 155, page 13 of the filing PDF)32
156Novolog Flexpen inj 3 mL (Orange)00169633910Listed by the FDA as Novologinsulin aspart100 IU/mLinjection, solutionNovo Nordisk6,264.55 (Schedule G, line 156, page 13 of the filing PDF)80
157Steqeyma 90 mg/mL syr 1=172606002801Listed by the FDA as Steqeymaustekinumab-stba90 mg/mLinjection, solutionCELLTRION USA, Inc.6,192.63 (Schedule G, line 157, page 13 of the filing PDF)fewer than 6 (the count is not shown)
158Arnuity Ellipta 100 mcg oral inh 3000173087410Listed by the FDA as Arnuity Elliptafluticasone furoate100 mcgpowderGlaxoSmithKline LLC6,140.89 (Schedule G, line 158, page 13 of the filing PDF)125
159Austedo tab 6 mg68546017060Listed by the FDA as Austedodeutetrabenazine6 mgtablet, coatedTeva Neuroscience, Inc.6,101.95 (Schedule G, line 159, page 13 of the filing PDF)fewer than 6 (the count is not shown)
160Lokelma 10 g Packets00310111030Listed by the FDA as Lokelmasodium zirconium cyclosilicate10 g/10 gpowder, for suspensionAstraZeneca Pharmaceuticals LP6,046.92 (Schedule G, line 160, page 13 of the filing PDF)14
161Wixela Inhub Diskus 100/50 mcg 60S00378932032Listed by the FDA as Wixela Inhubfluticasone propionate and salmeterol100 mcg; 50 mcgpowderMylan Pharmaceuticals Inc.6,035.91 (Schedule G, line 161, page 13 of the filing PDF)185
162Fluticasone HFA 220 mcg oral inh66993008096Listed by the FDA as Fluticasone Propionate HFA220 mcgaerosol, meteredPrasco Laboratories5,920.76 (Schedule G, line 162, page 13 of the filing PDF)42
163Liraglutide 18 mg/3 mL inj pen (3PK)00480366722Listed by the FDA as Liraglutide6 mg/mLinjectionTeva Pharmaceuticals USA, Inc.5,900.80 (Schedule G, line 163, page 13 of the filing PDF)27
164Breyna 80/4.5 mcg oral inh (120 inh)00378750232Listed by the FDA as Breynabudesonide and formoterol fumarate80 mcg; 4.5 mcgaerosol, meteredMylan Pharmaceuticals Inc.5,802.39 (Schedule G, line 164, page 13 of the filing PDF)46
165Eliquis 5 mg tablets00003089421Listed by the FDA as Eliquisapixaban5 mgtablet, film coatedE.R. Squibb & Sons, L.L.C.5,757.25 (Schedule G, line 165, page 13 of the filing PDF)216
166Tradjenta 5 mg tablets00597014030Listed by the FDA as Tradjentalinagliptin5 mgtablet, film coatedBoehringer Ingelheim Pharmaceuticals, Inc.5,562.13 (Schedule G, line 166, page 13 of the filing PDF)171
167Biktarvy tab61958250103Listed by the FDA as Biktarvybictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate50 mg; 200 mg; 25 mgtabletGilead Sciences, Inc.5,562.12 (Schedule G, line 167, page 13 of the filing PDF)fewer than 6 (the count is not shown)
168Ventolin HFA inh W/DOS CTR 200puffs00173068220Listed by the FDA as Ventolin HFAalbuterol sulfate90 mcgaerosol, meteredGlaxoSmithKline LLC5,284.57 (Schedule G, line 168, page 13 of the filing PDF)321
169Otezla 28 day Starter pack55513036955Listed by the FDA as OtezlaapremilastkitAmgen, Inc5,259.32 (Schedule G, line 169, page 13 of the filing PDF)fewer than 6 (the count is not shown)
170Zoryve 0.15% cream 60 g80610011560Listed by the FDA as Zoryveroflumilast1.5 mg/gcreamArcutis Biotherapeutics, Inc.5,258.79 (Schedule G, line 170, page 13 of the filing PDF)9
171Levalbuterol HFA inh (200PF) 15 g00591292754Listed by the FDA as Levalbuterol tartrate HFA inhalationlevalbuterol tartrate45 mcgaerosol, meteredActavis Pharma, Inc.5,158.93 (Schedule G, line 171, page 13 of the filing PDF)175
172Valtoco 15 mg NAS SP(10x7.5 mg)5 dose72252051510Listed by the FDA as Valtocodiazepam7.5 mg/0.1 mLsprayNeurelis, Inc5,038.15 (Schedule G, line 172, page 14 of the filing PDF)fewer than 6 (the count is not shown)
Total Prescription Drugs individually under $5,000568,968.95 (Schedule G, row for amounts under $5,000, page 14 of the filing PDF)43,637 (Schedule G, claims on the row for amounts under $5,000, page 14 of the filing PDF)
Total Costs of Prescription Drugs Obtained Through 340B Program Claimed for Reimbursement8,143,697.89 (Schedule G, printed total, page 14 of the filing PDF)61,847 (Schedule G, printed claims total, page 14 of the filing PDF)

What “fewer than 6” means. A count of 1 to 5 is not shown on this site or in its data files. Methods, section 9, says how.

Amounts and counts are the filer’s own, in US dollars. They are written here with commas between thousands, and an amount filed with one decimal place is written with two. No value is changed: the filing and the download keep each figure as typed.

Drug names are the filer’s own words. Filers type them in many ways, so this page writes them one way: capitals, spaces, unit names such as mg and mL, a zero before a decimal point, and commas in long numbers. No word is changed, spelled out or left out, and shorthand stays as the filer typed it. The filing and the download keep each name as typed, and a search here reads both.

“Listed by the FDA as” is not part of the filing. It is the name, ingredient, strength, form and labeler that the U.S. Food and Drug Administration’s National Drug Code Directory lists for the row’s code, as downloaded on 11 November 2026. All 172 rows have one. A row has none when its code is not filed as one 11-digit code or the directory has never listed it. Where the directory has since dropped a code, the name is kept as it was last listed, and the line says so. The directory’s capitals, strengths and unit names are written one way on this page. How a code is matched

Source

Filing PDF
Open Schedule G on the State of Rhode Island's website
SHA-256
fb7ac35095fe2e677e8569bf5a2d6f6c213006b8c6b004b012083af7608d67ea
Retrieved
11 November 2026
Pages used
9 to 14 of 16